Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

BeOne Medicines (ONC) Drug Pipeline

Drug pipeline
Drug NameConditionStageStatusStudy NameTrial Start DateArticle
Sonrotoclax, Bgb-11417Hepatic Impairment, Healthy Adult ParticipantsPhase INot Yet RecruitingA Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Sonrotoclax in Participants With Severe Hepatic ImpairmentSep 29, 2026
Tacabrutideg, Bgb-16673Hepatic Impairment, Healthy Adult ParticipantsPhase INot Yet RecruitingA Study to Investigate Safety, Tolerability, and Pharmacokinetics of Tacabrutideg (BGB-16673) in Participants With Moderate and Severe Hepatic ImpairmentSep 29, 2026
Lenvatinib, Sorafenib, Bgb-B2033Hepatocellular Carcinoma, Liver CancerPhase IIINot Yet RecruitingStudy Comparing BGB-B2033 With Sorafenib or Lenvatinib in Relapsed Hepatocellular CarcinomaSep 17, 2026
Rosuvastatin, Midazolam, Celecoxib, Dabigatran Etexilate, Bgb-43395Healthy Adult ParticipantsPhase IRecruitingA Trial in Healthy Participants to Assess Drug Interaction Potential of BGB-43395Sep 10, 2026―
Cetuximab, Tislelizumab, Bg-85738Advanced Solid Tumor, Metastatic Solid Tumor, Ras MutationPhase IRecruitingA First-in-Human Study Investigating BG-85738 Alone or in Combination With Other Antitumor Agents in Patients With Advanced or Metastatic Solid Tumors With Rat Sarcoma Virus (RAS) MutationsJul 30, 2026
Leucovorin, Oxaliplatin, Tislelizumab, 5-FluorouracilMetastatic Esophageal Squamous Cell Carcinoma, Advanced Esophageal Squamous Cell CarcinomaPhase IIRecruitingA Study Investigating Alternate Schedules of Tislelizumab Plus Chemotherapy in Japanese Patients With First-line Advanced ESCCJul 22, 2026
Bgb-58067 TabletHealthy VolunteersPhase IRecruitingA Study to Investigate the Relative Bioavailability of 2 Tablet Formulations and the Effect of Food on the Pharmacokinetics of BGB-58067 in Healthy ParticipantsJul 09, 2026
Dexamethasone, Azacitidine, Sonrotoclax, Inotuzumab Ozogamicin, Bgb-11417Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Pediatric Cancer, B-Cell Acute Lymphoblastic Leukemia, Refractory Acute Myeloid Leukemia, Relapsed Acute Myeloid Leukemia, R/R Aml, Pediatric All, Relapsed, Pediatric All, Pediatric All, B Cell, Pediatric Aml, R/R B-Cell Allphase1AndPhase2Not Yet RecruitingA Study of Sonrotoclax (BGB-11417) in Children With Relapsed or Refractory Acute Myeloid Leukemia and B-cell Acute Lymphoblastic LeukemiaMay 29, 2026
Hh160Endometrial Cancer, Non-small Cell Lung Cancer, Colorectal Cancer, Renal Cell Carcinoma, Cervical Cancer, Triple Negative Breast Cancer, Head And Neck Squamous Cell Carcinoma, Hepatocellular Carcinoma, Solid Tumor, Gastroesophageal Adenocarcinoma, Small-cell Lung Cancer, Urothelial CarcinomaPhase IRecruitingA First-in-Human Study of HH160 in Participants With Advanced or Metastatic Solid TumorsMay 29, 2026
Bg-75202, Hypomethylation AgentMyeloid MalignancyPhase IRecruitingAn Investigational Study of BG-75202 Alone and in Combination With Other Agents in Patients With Myeloid MalignanciesMay 22, 2026

FAQ

What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does BeOne Medicines (ONC) have in its pipeline
BeOne Medicines ONC is currently developing the following drugs: Sonrotoclax, Bgb-11417, Tacabrutideg, Bgb-16673, Lenvatinib, Sorafenib, Bgb-B2033, Rosuvastatin, Midazolam, Celecoxib, Dabigatran Etexilate, Bgb-43395, Cetuximab, Tislelizumab, Bg-85738, Leucovorin, Oxaliplatin, Tislelizumab, 5-Fluorouracil, Bgb-58067 Tablet, Dexamethasone, Azacitidine, Sonrotoclax, Inotuzumab Ozogamicin, Bgb-11417, Hh160, Bg-75202, Hypomethylation Agent, Sonrotoclax Tablet For Oral Suspension, Sonrotoclax Tablet, Bgb-11417, Itraconazole, Phenytoin, Bgb-58067, Leucovorin, Oxaliplatin, 5-Fluorouracil, Tislelizumab, Capecitabine, Abemaciclib, Letrozole, Ribociclib, Palbociclib, Bgb-43395, Bg-C0979, Tislelizumab, Bg-A3004, Venetoclax, Zanubrutinib, Acalabrutinib, Sonrotoclax, Fulvestrant, Bgb-43395, Bg-75098, Aromatase Inhibitor, Bg-75202, Cdk4 Inhibitor, Estrogen Receptor Antagonist, Bg-C0902, Zanubrutinib, Bgb-3111, Brukinsa, Sonrotoclax, Zanubrutinib, Bg-71332, Bgb-45035, Oxaliplatin, Capecitabine, Cisplatin, Leucovorin, 5-Fluorouracil, Subcutaneous Tislelizumab, Intravenous Tislelizumab, Bgb-16673, Pirtobrutinib, Bgb-16673, Rituximab, Bendamustine, Methylprednisolone, Bgb-16673, Rituximab, Venetoclax, Obinutuzumab, Sonrotoclax, Itraconazole, Phenytoin, Bgb-16673, Rituximab, Bendamustine, Venetoclax, Idelalisib, Bgb-16673, Chemotherapy, Bgb-B455, [14C]-Bgb-16673, Bgb-43395, Fulvestrant, Bgb-43395, Bgb-21447, Sonrotoclax, Zanubrutinib, Bg-60366, Zanubrutinib, Sonrotoclax, Obinutuzumab, Sonrotoclax, Zanubrutinib, Bgb-16673, Glofitamab, Mosunetuzumab, Bg-C137. These drug candidates are in various stages of clinical development as the company works toward FDA approval.